Although ILD complication was seen in 57% of RA individuals who had autoantibodies against ARS, treatment with MTX and bDMARDs could possibly be and effectively administered safely
Although ILD complication was seen in 57% of RA individuals who had autoantibodies against ARS, treatment with MTX and bDMARDs…